Circular Genomics: Funding, Investors & Team (Oct 2026)
Circular Genomics, headquartered in Albuquerque, New Mexico, is a biotech and genomics firm that focuses on creating RNA-based assays for diagnosing and treating psychiatric and neurological disorders. Established in 2021, this company specializes in the development of innovative solutions in these fields.
Circular Genomics has raised $27.8M across 3 funding rounds on record, the most recent a Series A of $15.0M announced in Dec 2025.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Circular Genomics Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Circular Genomics Funding Rounds
Circular Genomics raised $4.5M in a Seed announced in Dec 2021.
2.1 years later, a Series A of $8.3M was announced in Jan 2024.
1.9 years later, a Series A of $15.0M was announced in Dec 2025.
Circular Genomics Founders and Leadership Team
Contact details for the Circular Genomics team: 1 of 2 have an email address on file.
Start 14-day free trial →Circular Genomics Funding Compared to Other Biotechnology Startups
Circular Genomics' latest round of $15.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Circular Genomics in Biotechnology and Albuquerque
Companies Similar to Circular Genomics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Circular Genomics Funding FAQs
What does Circular Genomics do?
Circular Genomics, headquartered in Albuquerque, New Mexico, is a biotech and genomics firm that focuses on creating RNA-based assays for diagnosing and treating psychiatric and neurological disorders. Established in 2021, this company specializes in the development of innovative solutions in these fields.
How much funding has Circular Genomics raised?
Circular Genomics has raised $27.8M across 3 rounds on record. The most recent is a Series A of $15.0M announced in Dec 2025.
When did Circular Genomics last raise funding?
Circular Genomics' most recent funding round on record is a Series A of $15.0M, announced in Dec 2025.
Who founded Circular Genomics?
FundedIQ lists Alexander Hafez (Founder), Nikolaos Mellios (Founder) at Circular Genomics.
Where is Circular Genomics headquartered?
Circular Genomics is based in Albuquerque, New Mexico, United States.
How many employees does Circular Genomics have?
Circular Genomics is in the 1-10 employee band.
How does Circular Genomics' funding compare to other Biotechnology startups?
Circular Genomics' latest round of $15.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Circular Genomics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Circular Genomics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.